Organization
University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy
7 abstracts
Abstract
AN UPDATE ON THE INTEGRATED SAFETY ANALYSIS OF FILGOTINIB IN PATIENTS WITH MODERATE TO SEVERE ACTIVE RHEUMATOID ARTHRITIS OVER A MEDIAN OF 4.3 YEARSOrg: Oregon Health and Science University, School of Medicine, Portland, United States of America, Medical University of Vienna, Department of Medicine III, Division of Rheumatology, Vienna, Austria, University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, ASST Gaetano Pini-CTO, Department of Rheumatology and Medical Sciences, Milan, Italy, University of Occupational and Environmental Health, Department of Internal Medicine, Kitakyushu, Japan,
Abstract
APPLICATION OF A PREDICTION MODEL TO IDENTIFY PSORIATIC ARTHRITIS PATIENTS WITH A HIGHER DIFFICULTNESS-TO-TREAT – ANALYSIS FROM A SINGLE-CENTRE COHORTOrg: University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, ASST Gaetano Pini-CTO, Department of Clinical Rheumatology, Milan, Italy, ASST Gaetano Pini-CTO, Bone Disease Unit, Milan, Italy, University of Milan, Department of Biomedical and Clinical Sciences “L. Sacco”, Milan, Italy,
Abstract
ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES ASSOCIATED INTERSTITIAL PNEUMONIA: A NEW CLINICAL ENTITY?Org: University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, ASST G. Pini-CTO. UOC Clinica Reumatologica, Milan, Italy, UO di Pneumologia e Terapia Semi-Intensiva Respiratoria - Servizio di Fisiopatologia Respiratoria ed Emodinamica Polmonare, MultiMedica IRCCS, Milan, Italy,
Abstract
ARE OSTEOPOROSIS AND FRACTURES NEGLECTED ISSUES IN AXIAL SPONDYLOARTHRITIS? DATA FROM A CROSS-SECTIONAL MONOCENTRIC STUDYOrg: ASST G. Pini-CTO, Department of Rheumatology and Medical Sciences, Milan, Italy, University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, ASST G. Pini-CTO, Department of Rheumatology and Medical Sciences, Bone Disease Unit, Milan, Italy,
Abstract
ANTIINFLAMMATORY, ANTIOXIDANT AND ANTI-ATHEROSCLEROTIC EFFECTS OF A COMBINATION OF NATURAL SUPPLEMENTS ON PATIENTS WITH FMF RELATED AA AMYLOIDOSIS: A NON-RANDOMIZED 24 WEEKS OPEN LABEL INTERVENTIONAL STUDYOrg: Schulich School of Medicine & Dentistry, University of Western Ontario, Paediatric Rheumatology, London, Canada, Western University, London, Ontario, Canada, Paediatrics, London, Canada, University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, Epigenetic Health Solutions, Unit of Nephrology, Ankara, Turkey,
Abstract
ANTICENTROMERE ANTIBODIES IN THE SETTING OF SJÖGREN SYNDROME: ANALYSIS OF A MULTICENTRIC COHORTOrg: University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy, ASST G. Pini-CTO, UOC Clinica Reumatologica, Milan, Italy, Rheumatology Unit, Department of Clinical and Experimental Medicine, Milan, Italy, UOC Reumatologia, AOU Policlinico Umberto I, Rome, Italy, Saint Camillus International University of Health Science, Rome, Italy,
Abstract
ACPA POSITIVITY DETERMINES REMISSION IN PATIENTS WITH RA TREATED WITH IV AND SC ABATACEPT: A POST HOC ANALYSIS OF THE REAL-WORLD OBSERVATIONAL ACTION AND ASCORE STUDIESOrg: Schlosspark-Klinik, University Medicine Berlin, Department of Internal Medicine, Rheumatology, Berlin, Germany, Bristol Myers Squibb, Medical Immunology & Fibrosis, Munich, Germany, Bristol Myers Squibb, MESP France – Market Access, Rueil-Malmaison, France, ARC Amsterdam University Hospitals – VU University Medical & Reade, Department of Rheumatology, Amsterdam, Netherlands, Bristol Myers Squibb, Global Drug Development, Princeton, United States of America,